Clinical Trial: Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional




Official Title: MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis II

Brief Summary: The aim of this study is to assess the efficacy of a rituximab regimen based on rate of ANCA and CD19 lymphocytes for maintenance treatment in systemic ANCA-associated vasculitis: prospective, multicenter, controlled, randomized comparative study of two rituximab regimens: one based on ANCA and CD19 lymphocytes versus systematic infusions.